Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in BehaVR, a leading innovator in virtual reality (VR) digital wellness and digital therapeutics experiences.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221213005174/en/
Accenture has made a strategic investment, through Accenture Ventures, in BehaVR, a leading innovator in virtual reality (VR) digital wellness and digital therapeutics experiences. (Photo: Business Wire)
On the same day, BehaVR announced a merger with OxfordVR, a spin-out of Oxford University and a leader in science-based virtual reality treatments for serious mental illnesses. The newly combined entity will offer comprehensive, cross-acuity, VR-based therapeutic interventions for mental health, part of a digital therapeutics market expected to exceed $13B by 2027.
Through its proprietary delivery platform for creating, validating, and operating digital therapeutics solutions, the BehaVR platform enables personalized, dynamic experiences that are governed and adapted in real-time based on biometrics, protocols, and machine learning models.
Healthcare leaders expect virtual reality and the metaverse to positively impact the future of care, according to the Accenture Digital Health Technology Vision 2022 report, which explains how more meaningful, tailored experiences can further humanize healthcare by aligning the right technology, operating model, data, and culture to deliver more efficient and empathetic care.
"Providing people with the flexibility to decide when, where, and how they want to receive mental health care will help to improve access, experience, and outcomes," said Rich Birhanzel, senior managing director and Health practice global lead at Accenture. "BehaVR offers people choice and clinicians options to expand how they care for patients."
BehaVR is now part of Accenture Ventures’ Project Spotlight, an engagement and investment program that connects emerging technology startups with the Global 2000 to fill strategic innovation gaps. Project Spotlight offers extensive access to Accenture’s domain expertise and its enterprise clients, helping startups harness human creativity and deliver on the promise of their technology.
“Mental health issues in the U.S. and around the world have never been more prevalent, and there is an urgent need for increased resources and treatment,” said Tom Lounibos, managing director, Accenture Ventures. “BehaVR is using the immersive power of virtual reality to activate and rewire neural pathways to treat people suffering from anxiety, stress, fear and other conditions.”
“Around the world, providers and employers are grappling with how to enhance the depth, breadth and efficacy of their mental health service offerings, and we believe virtual reality-based digital therapeutics can play a vital role in helping them do all of those things,” said Aaron Gani, founder and CEO of BehaVR. “Joining Accenture Ventures’ Project Spotlight is a powerful way to drive increased awareness of BehaVR’s VR-powered mental health services as we continue our work to lower barriers and deliver advanced care to the people that so desperately need it.”
About Accenture
Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Technology and Operations services and Accenture Song — all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 721,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Visit us at accenture.com.
About BehaVR
BehaVR is the leader in building evidence-based, immersive, digital therapeutics designed to create a more resilient world, liberated from fear and pain. Its suite of clinically validated therapeutics offer access to treatments on a spectrum across mental wellness and mental and behavioral conditions, including validated treatments for serious mental illness. BehaVR is the first immersive digital therapeutics company to deliver these treatments on an integrated platform that simplifies the patient experience, enables clinician oversight, and generates patient-specific care plans and measurable outcomes. Combining a team of accomplished clinicians and researchers with proven healthcare veterans and technology innovators, BehaVR is dedicated to improving access to better mental health through immersive technology. For more information, visit us at BehaVR.com.
Copyright © 2022 Accenture. All rights reserved. Accenture and its logo are trademarks of Accenture. This content is provided for general information purposes and is not intended to be used in place of consultation with our professional advisors. This document refers to marks owned by third parties. All such third-party marks are the property of their respective owners. No sponsorship, endorsement or approval of this content by the owners of such marks is intended, expressed or implied.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221213005174/en/
Contacts
Marchell Gillis
Accenture
+1 678 657 7515
marchell.gillis@accenture.com
